Benzinga | Nov 5, 2020 07:13AM EST

Agios Pharmaceuticals Q3 EPS $(1.43) Misses $(1.38) Estimate, Sales $34.71M Miss $38.02M Estimate

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(1.38) by 3.62 percent. This is a 20.99 percent increase over losses of $(1.81) per share from the same period last year. The company reported quarterly sales of $34.71 million which missed the analyst consensus estimate of $38.02 million by 8.72 percent. This is a 33.36 percent increase over sales of $26.02 million the same period last year.